13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


臨床試験数 : 3,340 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00645749
(ClinicalTrials.gov)
July 200825/3/2008Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple SclerosisHelminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple SclerosisRelapsing Remitting Multiple SclerosisBiological: Helminth ovaUniversity of Wisconsin, MadisonNational Multiple Sclerosis SocietyCompleted18 Years50 YearsAll17Phase 1United States